Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-012986
Filing Date
2015-06-26
Accepted
2015-06-26 17:06:10
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q erb20150331_10q.htm 10-Q 688583
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12291
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12131
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5240
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5295
  Complete submission text file 0001437749-15-012986.txt   2943241

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS erb-20150331.xml EX-101.INS 372013
7 EXHIBIT 101.SCH erb-20150331.xsd EX-101.SCH 36054
8 EXHIBIT 101.CAL erb-20150331_cal.xml EX-101.CAL 36421
9 EXHIBIT 101.DEF erb-20150331_def.xml EX-101.DEF 179994
10 EXHIBIT 101.LAB erb-20150331_lab.xml EX-101.LAB 239676
11 EXHIBIT 101.PRE erb-20150331_pre.xml EX-101.PRE 179920
Mailing Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127
Business Address 2140 NORTH MIAMI AVENUE MIAMI FL 33127 305-324-2300
ERBA Diagnostics, Inc. (Filer) CIK: 0001095858 (see all company filings)

EIN.: 113500746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14798 | Film No.: 15955919
SIC: 2834 Pharmaceutical Preparations